Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Pafre MR 250mg/50mg/325mg Tablet

Prescription Icon
Prescription Required

Marketer

Arlak Biotech Pvt Ltd

Salt Composition

Chlorzoxazone (250mg) + Diclofenac (50mg) + Paracetamol (325mg)

Overview Pafre MR 250mg/50mg/325mg Tablet

Combiflex Relief 250mg/50mg/325mg tablets offer combined pain relief for muscle spasms. This medication enhances muscle mobility and alleviates pain and discomfort related to muscle spasms. For optimal absorption and to minimize stomach upset, take Combiflex Relief with food, as directed by your physician. Strict adherence to the prescribed dosage and duration is crucial. Common side effects include nausea, vomiting, indigestion, abdominal pain, diarrhea, appetite suppression, and dry mouth. Persistent or bothersome side effects warrant immediate medical attention; your doctor can offer strategies for managing them. Prior to use, inform your doctor of any pre-existing heart, kidney, or liver conditions, and disclose all other medications you are currently taking. This medication is not universally suitable; pregnant or breastfeeding individuals should seek medical counsel before use.

Uses of Pafre MR 250mg/50mg/325mg Tablet

Managing musculoskeletal pain stemming from muscle contractions

Major Benefits of Pafre MR 250mg/50mg/325mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Pafre MR 250mg/50mg/325mg Tablet whole; do not damage it by chewing, crushing, or breaking. Administer this medication with food.

Common Side effects of Pafre MR 250mg/50mg/325mg Tablet:

  • Nausea
  • Vomiting
  • Heartburn
  • Stomach pain
  • Diarrhea
  • Loss of appetite
  • Dryness in mouth

How to use Pafre MR 250mg/50mg/325mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Pafre MR 250mg/50mg/325mg Tablet should be administered with a meal.

How Pafre MR 250mg/50mg/325mg Tablet works:

Each Pafre MR 250mg/50mg/325mg tablet unites a muscle relaxant (Chlorzoxazone) with analgesics (Diclofenac and Paracetamol). Chlorzoxazone alleviates muscle tension and spasms by acting on the central nervous system, enhancing muscle mobility. Diclofenac and Paracetamol concurrently reduce pain and inflammation by inhibiting the production of pain-signaling compounds and inflammatory mediators.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Pafre MR 250mg/50mg/325mg Tablet lacks established safety data. Physician consultation is advised.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on the use of Pafre MR 250mg/50mg/325mg Tablet in pregnancy is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the use of Pafre MR 250mg/50mg/325mg tablets while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Pafre MR 250mg/50mg/325mg Tablet on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding the use of Pafre MR 250mg/50mg/325mg tablets in individuals with renal impairment. Seek medical advice from your physician.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Pafre MR 250mg/50mg/325mg Tablet use in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Pafre MR 250mg/50mg/325mg Tablet :

Should you forget to take your Pafre MR 250mg/50mg/325mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Pafre MR 250mg/50mg/325mg Tablet

LabelValue
Potential for Dependence None.
Medication Classification Medication for Pain Relief

FAQs on Pafre MR 250mg/50mg/325mg Tablet

The combined analgesic Pafre MR 250mg/50mg/325mg Tablet contains diclofenac, paracetamol, and chlorzoxazone. This formulation provides muscle pain relief. Its muscle relaxant component, chlorzoxazone, acts centrally. Diclofenac and paracetamol reduce pain and inflammation by inhibiting prostaglandin production.
Most individuals tolerate Pafre MR 250mg/50mg/325mg Tablets well. Nevertheless, some users may experience typical adverse reactions such as nausea, vomiting, indigestion, abdominal discomfort, diarrhea, anorexia, dry mouth, fatigue, drowsiness, or less frequent or infrequent side effects. Report any ongoing medication-related issues to your physician promptly.
Continue taking Pafre MR 250mg/50mg/325mg tablets as directed by your physician for the prescribed period. Discontinuation is acceptable if used solely for transient pain management.
Nausea and vomiting are potential side effects of Pafre MR 250mg/50mg/325mg Tablets. If nausea occurs, consume the tablet with milk, food, or an antacid. Refrain from ingesting fatty or fried foods concurrently. If vomiting develops, replenish fluids by sipping small amounts of water or other liquids frequently. Persistent vomiting accompanied by dehydration symptoms, such as dark, strong-smelling urine and infrequent urination, warrants immediate medical consultation. Do not use other medications without first consulting your physician.
Dizziness, including lightheadedness, faintness, weakness, or unsteadiness, is a potential side effect of Pafre MR 250mg/50mg/325mg Tablets in certain individuals. Experiencing these symptoms warrants a period of rest; activities should be resumed only after the dizziness subsides.
Prolonged consumption of Pafre MR 250mg/50mg/325mg tablets can indeed harm the kidneys. Healthy kidneys naturally generate prostaglandins, chemicals vital for their protection. Analgesic medications reduce prostaglandin levels, increasing the risk of kidney damage with extended use. Patients with pre-existing kidney conditions should avoid using such painkillers.
Exceeding the prescribed dosage of Pafre MR 250mg/50mg/325mg tablets elevates the probability of adverse reactions. Should your pain worsen or remain unalleviated despite adhering to the recommended dosage, seek medical advice for reassessment.
Store the medication in its original, tightly sealed container or packaging, following the storage instructions provided on the label. Discard any remaining medication after use. Prevent access by children, pets, and others.
Pafre MR 250mg/50mg/325mg...
45
MRP 55
17% off